300 related articles for article (PubMed ID: 33919157)
1. Myelopoiesis during Solid Cancers and Strategies for Immunotherapy.
Wildes TJ; DiVita Dean B; Flores CT
Cells; 2021 Apr; 10(5):. PubMed ID: 33919157
[TBL] [Abstract][Full Text] [Related]
2. Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis.
Wu C; Ning H; Liu M; Lin J; Luo S; Zhu W; Xu J; Wu WC; Liang J; Shao CK; Ren J; Wei B; Cui J; Chen MS; Zheng L
J Clin Invest; 2018 Aug; 128(8):3425-3438. PubMed ID: 29771686
[TBL] [Abstract][Full Text] [Related]
3. Generation of Myeloid Cells in Cancer: The Spleen Matters.
Wu C; Hua Q; Zheng L
Front Immunol; 2020; 11():1126. PubMed ID: 32582203
[TBL] [Abstract][Full Text] [Related]
4. Cancer-induced systemic myeloid dysfunction: Implications for treatment and a novel nanoparticle approach for its correction.
Alvarez R; Oliver L; Valdes A; Mesa C
Semin Oncol; 2018 Jan; 45(1-2):84-94. PubMed ID: 30318088
[TBL] [Abstract][Full Text] [Related]
5. Implications of metabolism-driven myeloid dysfunctions in cancer therapy.
Strauss L; Guarneri V; Gennari A; Sica A
Cell Mol Immunol; 2021 Apr; 18(4):829-841. PubMed ID: 33077904
[TBL] [Abstract][Full Text] [Related]
6. T-cell-Secreted TNFα Induces Emergency Myelopoiesis and Myeloid-Derived Suppressor Cell Differentiation in Cancer.
Al Sayed MF; Amrein MA; Bührer ED; Huguenin AL; Radpour R; Riether C; Ochsenbein AF
Cancer Res; 2019 Jan; 79(2):346-359. PubMed ID: 30389698
[TBL] [Abstract][Full Text] [Related]
7. Promotion of Expansion and Differentiation of Hematopoietic Stem Cells by Interleukin-27 into Myeloid Progenitors to Control Infection in Emergency Myelopoiesis.
Furusawa J; Mizoguchi I; Chiba Y; Hisada M; Kobayashi F; Yoshida H; Nakae S; Tsuchida A; Matsumoto T; Ema H; Mizuguchi J; Yoshimoto T
PLoS Pathog; 2016 Mar; 12(3):e1005507. PubMed ID: 26991425
[TBL] [Abstract][Full Text] [Related]
8. Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy.
Lebegge E; Arnouk SM; Bardet PMR; Kiss M; Raes G; Van Ginderachter JA
Front Immunol; 2020; 11():1395. PubMed ID: 32733461
[TBL] [Abstract][Full Text] [Related]
9. Tissue Site and the Cancer Immunity Cycle.
Horton BL; Fessenden TB; Spranger S
Trends Cancer; 2019 Oct; 5(10):593-603. PubMed ID: 31706507
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated myeloid cells in cancer immunotherapy.
Cheng X; Wang H; Wang Z; Zhu B; Long H
J Hematol Oncol; 2023 Jul; 16(1):71. PubMed ID: 37415162
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells.
Schürch CM; Riether C; Ochsenbein AF
Cell Stem Cell; 2014 Apr; 14(4):460-72. PubMed ID: 24561082
[TBL] [Abstract][Full Text] [Related]
12. Differentiation and characterization of myeloid cells.
Gaines P; Berliner N
Curr Protoc Immunol; 2005 Jul; Chapter 22():Unit 22F.5. PubMed ID: 18432952
[TBL] [Abstract][Full Text] [Related]
13. Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients.
Wu WC; Sun HW; Chen HT; Liang J; Yu XJ; Wu C; Wang Z; Zheng L
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4221-6. PubMed ID: 24591638
[TBL] [Abstract][Full Text] [Related]
14. Emerging Principles in Myelopoiesis at Homeostasis and during Infection and Inflammation.
Schultze JL; Mass E; Schlitzer A
Immunity; 2019 Feb; 50(2):288-301. PubMed ID: 30784577
[TBL] [Abstract][Full Text] [Related]
15. Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy.
Kamran N; Chandran M; Lowenstein PR; Castro MG
Clin Immunol; 2018 Apr; 189():34-42. PubMed ID: 27777083
[TBL] [Abstract][Full Text] [Related]
16. Harnessing immune checkpoints in myeloid lineage cells for cancer immunotherapy.
Park SY; Kim IS
Cancer Lett; 2019 Jun; 452():51-58. PubMed ID: 30910590
[TBL] [Abstract][Full Text] [Related]
17. Targeting myeloid cells in the tumor sustaining microenvironment.
Schupp J; Krebs FK; Zimmer N; Trzeciak E; Schuppan D; Tuettenberg A
Cell Immunol; 2019 Sep; 343():103713. PubMed ID: 29129292
[TBL] [Abstract][Full Text] [Related]
18. IL-33-induced hematopoietic stem and progenitor cell mobilization depends upon CCR2.
Kim J; Kim W; Le HT; Moon UJ; Tran VG; Kim HJ; Jung S; Nguyen QT; Kim BS; Jun JB; Cho HR; Kwon B
J Immunol; 2014 Oct; 193(7):3792-802. PubMed ID: 25143444
[TBL] [Abstract][Full Text] [Related]
19. Concise Review: Modulating Cancer Immunity with Hematopoietic Stem and Progenitor Cells.
Wildes TJ; Flores CT; Mitchell DA
Stem Cells; 2019 Feb; 37(2):166-175. PubMed ID: 30353618
[TBL] [Abstract][Full Text] [Related]
20. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
